Release Date: 20/09/10 12:32 Summary: Notice of Substantial Holder Price Sensitive: No Download Document 213.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%